<!DOCTYPE html>
<html lang="en">
<head>        <meta charset="utf-8">
        <meta name="viewport" content="width=device-width, initial-scale=1.0">    <link
        rel="stylesheet"
        href="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/css/bootstrap.min.css"
        integrity="sha384-Gn5384xqQ1aoWXA+058RXPxPg6fy4IWvTNh0E263XmFcJlSAwiGgFAW/dAiS6JXm"
        crossorigin="anonymous"
    />
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/c3/0.6.12/c3.min.css"/>
    <style>
        h2 {
            margin-top: 35px;
        }

        html, body {
            height: 100%;
        }

        body {
            display: flex;
            flex-flow: column;
        }

        .footer {
            margin-top: auto;
            padding-top: 1em;
            background-color: #f5f5f5;
        }
    </style>    <title>SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN</title></head>

<body>
<nav class="navbar navbar-expand-lg navbar-light bg-light">
    <span class="navbar-brand">
        Molecular Signatures Database
    </span>
</nav>

<div class="container" style="margin-top: 50px; margin-bottom: 50px">
<div class="card">
        <div class="card-header">
            SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN
        </div>
        <div class="card-body">
                <p>The B-MYB proto-oncogene is a transcription factor belonging to the MYB family that is frequently overexpressed or amplified in different types of human malignancies. While it is suspected that B-MYB plays a role in human cancer, there is still no direct evidence of its causative role. Looking for mutations of the B-MYB gene in human cell lines and primary cancer samples, we frequently isolated two nonsynonymous B-MYB polymorphic variants (rs2070235 and rs11556379). Compared to the wild-type protein, the B-MYB isoforms display altered conformation, impaired regulation of target genes and decreased antiapoptotic activity, suggesting that they are hypomorphic variants of the major allele. Importantly, the B-MYB polymorphisms are common; rs2070235 and rs11556379 are found, depending on the ethnic background, in 10-50% of human subjects. We postulated that, if B-MYB activity is important for transformation, the presence of common, hypomorphic variants might modify cancer risk. Indeed, the B-MYB polymorphisms are underrepresented in 419 cancer patients compared to 230 controls (odds ratio 0.53; (95%) confidence interval 0.385-0.755; P=0.001). This data imply that a large fraction of the human population is carrier of B-MYB alleles that might be associated with a reduced risk of developing neoplastic disease.</p>
            <dl>
                <dt>Local Unique Identifier</dt>
                <dd><a href="https://bioregistry.io/msigdb:M10651">M10651</a>
                </dd>
                    <dt>
                        <span class="badge badge-primary">Relation</span>
                            in taxon (<code>RO:0002162</code>)
                    </dt>
                    <dt>
                        <ol>
                                <li><a href="https://bioregistry.io/NCBITaxon:9606">NCBITaxon:9606</a></li>
                        </ol>
                    </dt>
                    <dt>
                        <span class="badge badge-primary">Relation</span>
                            has part (<code>BFO:0000051</code>)
                    </dt>
                    <dt>
                        <ol>
                                <li><a href="https://bioregistry.io/ncbigene:8556">ncbigene:8556</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:602">ncbigene:602</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:10013">ncbigene:10013</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3215">ncbigene:3215</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:23113">ncbigene:23113</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:7813">ncbigene:7813</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:5048">ncbigene:5048</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:51454">ncbigene:51454</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:8621">ncbigene:8621</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:4306">ncbigene:4306</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:7424">ncbigene:7424</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:816">ncbigene:816</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:1999">ncbigene:1999</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:4752">ncbigene:4752</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:54457">ncbigene:54457</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:9770">ncbigene:9770</a></li>
                        </ol>
                    </dt>
            </dl>
            <span class="badge badge-warning">Term generation via PyOBO is currently under construction</span>
            <blockquote>
                Term(reference=Reference(prefix=&#39;msigdb&#39;, identifier=&#39;M10651&#39;, name=&#39;SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN&#39;), definition=&#39;The B-MYB proto-oncogene is a transcription factor belonging to the MYB family that is frequently overexpressed or amplified in different types of human malignancies. While it is suspected that B-MYB plays a role in human cancer, there is still no direct evidence of its causative role. Looking for mutations of the B-MYB gene in human cell lines and primary cancer samples, we frequently isolated two nonsynonymous B-MYB polymorphic variants (rs2070235 and rs11556379). Compared to the wild-type protein, the B-MYB isoforms display altered conformation, impaired regulation of target genes and decreased antiapoptotic activity, suggesting that they are hypomorphic variants of the major allele. Importantly, the B-MYB polymorphisms are common; rs2070235 and rs11556379 are found, depending on the ethnic background, in 10-50% of human subjects. We postulated that, if B-MYB activity is important for transformation, the presence of common, hypomorphic variants might modify cancer risk. Indeed, the B-MYB polymorphisms are underrepresented in 419 cancer patients compared to 230 controls (odds ratio 0.53; (95%) confidence interval 0.385-0.755; P=0.001). This data imply that a large fraction of the human population is carrier of B-MYB alleles that might be associated with a reduced risk of developing neoplastic disease.&#39;, provenance=[Reference(prefix=&#39;pubmed&#39;, identifier=&#39;18026132&#39;, name=None)], relationships=defaultdict(&lt;class &#39;list&#39;&gt;, {TypeDef(reference=Reference(prefix=&#39;RO&#39;, identifier=&#39;0002162&#39;, name=&#39;in taxon&#39;), comment=None, namespace=None, definition=None, is_transitive=None, is_symmetric=None, domain=None, range=None, parents=[], xrefs=[], inverse=None, holds_over_chain=None): [Reference(prefix=&#39;NCBITaxon&#39;, identifier=&#39;9606&#39;, name=&#39;Homo sapiens&#39;)], TypeDef(reference=Reference(prefix=&#39;BFO&#39;, identifier=&#39;0000051&#39;, name=&#39;has part&#39;), comment=&#39;Inverse of part_of&#39;, namespace=None, definition=None, is_transitive=None, is_symmetric=None, domain=None, range=None, parents=[], xrefs=[], inverse=Reference(prefix=&#39;BFO&#39;, identifier=&#39;0000050&#39;, name=&#39;part of&#39;), holds_over_chain=None): [Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;8556&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;602&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;10013&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3215&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;23113&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;7813&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;5048&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;51454&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;8621&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;4306&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;7424&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;816&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;1999&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;4752&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;54457&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;9770&#39;, name=None)]}), properties=defaultdict(&lt;class &#39;list&#39;&gt;, {&#39;category_code&#39;: [&#39;C2&#39;], &#39;sub_category_code&#39;: [&#39;CGP&#39;], &#39;contributor&#39;: [&#39;Jessica Robertson&#39;], &#39;exact_source&#39;: [&#39;Table 2S: WT to ATG&#39;]}), parents=[], synonyms=[], xrefs=[], alt_ids=[], namespace=None, is_obsolete=False)
            </blockquote>
        </div>
    </div></div>

<footer class="footer">
    <p class="small text-center text-muted">
        Generated with PyOBO
    </p>
</footer>

<script src="https://code.jquery.com/jquery-3.2.1.slim.min.js"
        integrity="sha384-KJ3o2DKtIkvYIK3UENzmM7KCkRr/rE9/Qpg6aAZGJwFDMVNA/GpGFF93hXpG5KkN"
        crossorigin="anonymous"></script>
<script src="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/js/bootstrap.min.js"
        integrity="sha384-JZR6Spejh4U02d8jOt6vLEHfe/JQGiRRSQQxSfFWpi1MquVdAyjUar5+76PVCmYl"
        crossorigin="anonymous"></script></body>
</html>